Home » Authors » Cormac Sheridan

Articles by Cormac Sheridan

Arpida, Combio Collaborate For Antibiotics Discovery

Oct. 16, 2002

By Cormac Sheridan

Cytos Going Public By Way Of Merger With Swiss Company

Oct. 2, 2002

By Cormac Sheridan

Investors Hammer Genmab Stock Following Failure Of Lead Drug

Oct. 2, 2002

By Cormac Sheridan

Pharming Raises EUR8.2M In Equity, Debt, Prepares To Exit Moratorium

Oct. 2, 2002

By Cormac Sheridan

Investors Hammer Genmab Stock Following Failure Of Lead Drug

Oct. 2, 2002

By Cormac Sheridan

Cytos Going Public By Way Of Merger With Swiss Company

Oct. 2, 2002

By Cormac Sheridan

Pharming Raises EUR8.2M In Equity, Debt, Prepares To Exit Moratorium

Oct. 2, 2002

By Cormac Sheridan

Eirx Pharma Formed Through Three-Way Anglo-Irish Merger

Sep. 25, 2002

By Cormac Sheridan

Modex, IsoTis Plan To Merge Programs In Orthopedics, Skin

Sep. 25, 2002

By Cormac Sheridan

Eirx Pharma Formed Through Three-Way Anglo-Irish Merger

Sep. 25, 2002

By Cormac Sheridan

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...